# Calcium Vitamin D Bone Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/calcium-vitamin-d-bone-meta-analysis-evidence-review
Category: evidence-review
Summary: Calcium Vitamin D Bone Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are sy
Last reviewed: 2026-07-06
Reviewed by: Migaku Evidence Review
# Calcium Vitamin D Bone Meta-analysis: What the Evidence Says

## Quick Answer

Calcium Vitamin D Bone Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 systematic review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| The role of nutritional vitamin D on microinflammation and nutritional status in maintenance hemodialysis patients: a meta-analysis of randomized controlled trials | systematic review | 1 | 2026-05-29 | 10.3389/fnut.2026.1767616 |
| Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis | systematic review | 1 | 2026-01-01 | 10.1136/bmj-2025-088050 |

## What The Sources Report

- The persistence of the microinflammatory state in MHD can aggravate the occurrence of cardio-vascular events by worsening coronary artery calcification, which is an independent risk factor for cardiovascular events and the main cause of death in the MHD population. [Li Chen (2026); evidence level 1]
- Previous evidence has suggested a potential association between vitamin D status and micro-inflammatory state in hemodialysis patients. [Li Chen (2026); evidence level 1]
- Secondary outcomes included the risk of hip fracture, non-vertebral fracture, vertebral fracture, and falling, as well as the total number of falls. [Massé Olivier (2026); evidence level 1]
- If unpublished data, not obtained through personal communications, were found in another systematic review, we used that review to complete data extraction. [Massé Olivier (2026); evidence level 1]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For calcium vitamin d bone meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Li Chen (2026). The role of nutritional vitamin D on microinflammation and nutritional status in maintenance hemodialysis patients: a meta-analysis of randomized controlled trials. DOI: 10.3389/fnut.2026.1767616. PMCID: PMC13260404. PMID: 42293210. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13260404/
- Massé Olivier (2026). Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis. DOI: 10.1136/bmj-2025-088050. PMCID: PMC13188451. PMID: 42161415. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13188451/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.